Form 4 for TYRA Tyra Biosciences, Inc.
Accepted 2024-10-17 00:00:00 ET · period of report 2024-10-15 · accession 0000950170-24-115432 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2024-10-17 | 2024-10-15+ | TYRA | Harris Todd | Pres, CEO, Dir | S - Sale | $25.77 | -58.7K | 1.44M | -4% | -$1.51M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-16 | S | D | 3,922 | $26.98 | 1,434,041 | D | — | — | (F5) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $26.79 to $27.08. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 2 | Common | Common Stock | 2024-10-17 | S | D | 15,194 | $25.84 | 1,418,847 | D | — | — | (F6) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $25.30 to $26.16. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 3 | Common | Common Stock | 2024-10-17 | S | D | 200 | $26.37 | 1,418,647 | D | — | — | |
| 4 | Common | Common Stock | 2024-10-15 | S | D | 10,035 | $24.31 | 1,467,338 | D | — | — | (F2) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $24.00 to $24.8667. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 5 | Common | Common Stock | 2024-10-16 | S | D | 4,900 | $25.22 | 1,462,438 | D | — | — | (F3) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $24.72 to $25.59. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 6 | Common | Common Stock | 2024-10-16 | S | D | 24,475 | $26.23 | 1,437,963 | D | — | — | (F4) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $25.78 to $26.78. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |